Page 41 - Evogene Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: ST. LOUIS, Mo. and REHOVOT, Israel, March 17, 2021 /PRNewswire/ --  Plastomics, Inc., an agricultural biotech company, developing a step change in trait delivery technology, and Evogene Ltd.'s, (NASDAQ:EVGN) (TASE: EVGN), Ag-Seed division, focusing on discovery and development of seed traits, announced today a collaboration agreement targeting novel insect control traits for soybean.  As part of the collaboration, Plastomics, utilizing its disruptive new technology, will introduce Evogene's insect control genes demonstrating new modes of action (MoAs) into soybeans. These genes, whi...

REHOVOT, Israel (AP) _ Evogene Ltd. (EVGN) on Wednesday reported a loss of $8.1 million in its fourth quarter.The Rehovot, Israel-based company said it had a loss of 25 cents per share.The agricultural company posted revenue of $351,000 in the period.For the year, the company reported that its loss widened to $23.4 million, or 83 cents per share. Revenue was reported as $1 million.Evogene shares have risen 26% since the beginning of the year. The stock has more than quadrupled in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data...

/PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of...

ARK invests $8m in Israeli cannabis co InterCure ARK's Israeli ETF bought a 2.4% stake in InterCure, which is worth NIS 775 million. ARK Exchange Traded Funds (ETF) has invested $8 million in Israeli cannabis company InterCure (TASE: INCR). This is part of ARK's recent spending spree on Israeli companies after setting up an Israeli ETF. InterCure is set to merge with a SPAC (special purpose acquisition company) on the Canadian stock exchange, and ARK now has a 2.4% stake in InterCure worth NIS 775 million. ARK bought the shares at NIS 6.46, similar to today's price. RELATED ARTICLES InterCure...

Technavio Research: Agricultural Biotechnology Market Research 2021-2025 | 9.87% Year-Over-Year Growth Rate for 2021 | Technavio Technvaio forecast the global agricultural biotechnology market is expected to grow by USD 25.30 billion during 2021-2025. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of over 10%. This press release features multimedia. View the full relea...